We Think Janux Therapeutics (NASDAQ:JANX) Can Afford To Drive Business Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, Janux Therapeutics (NASDAQ:JANX) has seen its share price rise 241% over the last year, deligh

Simply Wall StJul 1 11:01 ET

Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA

Seeking AlphaJun 25 14:07 ET

Janux Therapeutics Insider Sold Shares Worth $82,125,000, According to a Recent SEC Filing

Jay Lichter, 10% Owner, Director, on June 03, 2024, sold 1,500,000 shares in Janux Therapeutics (JANX) for $82,125,000. Following the Form 4 filing with the SEC, Lichter has control over a total of 3,

MT NewswiresJun 6 03:12 ET

Janux Therapeutics(JANX.US) Officer Sells US$45.04 Million in Common Stock

$Janux Therapeutics(JANX.US)$ Officer Reardon Tighe sold 822.72K shares of common stock on Jun 3, 2024 at an average price of $54.75 for a total value of $45.04 million.Source: Announcement What is st

moomoo NewsJun 5 20:05 ET

JonesTrading Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $70

JonesTrading analyst Soumit Roy maintains $Janux Therapeutics(JANX.US)$ with a buy rating, and maintains the target price at $70.According to TipRanks data, the analyst has a success rate of 26.0% and

moomoo NewsJun 5 14:31 ET

Form 144 | Janux Therapeutics(JANX.US) Director Proposes to Sell 7.21 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 3, $Janux Therapeutics(JANX.US)$ Director Avalon BioVentures I, LP intends to sell 131.2K shares of its common stock on Jun 3, with a total market value of approximately $7

moomoo NewsJun 3 19:07 ET